NDC properties for NDC 9 17139-562
NDC item 17139056212
| NDC 9 | 17139-562 |
|---|---|
| NDC 10 | 17139-562-12 |
| NDC Item | 17139056212 |
| packaging | 1.25 g in 1 PACKET |
| DCSA | CIII |
| Labeler | ASCEND Therapeutics U.S., LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-02-17 |
| Marketing status | ACTIVE |
| NDA | NDA022309 |